GLP-1 drugs covered under the Bridge include tirzepatide (Zepbound, Foundayo) and semaglutide (Wegovy), prescribed specifically for weight loss
In terms of efficacy, after 24 weeks of treatment, the changes in body weight for different doses in the Retatrutide group were: -2.1% for the placebo group, -7.2% for the 1 mg group, -12.9% for the 4 mg group, -17.3% for the 8 mg group, and -17.5% for the 12 mg group
This is precisely what researchers at the UroGyn Specialists of Florida set out to explore in a pilot study from January 2023 to June 2024
What's still unconfirmed - the medical-group entity, full state list, exact billing cadence, and dispensing pharmacy - are reasonable things to weigh against the price before deciding it's worth it for you specifically
You still need to follow your labs
Pharmacokinetic analysis showed that stable steady-state concentrations could be achieved with once-daily dosing owing to the long half-life of oral semaglutide